The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
Although re-infection with Hepatitis C usually recurs rapidly following a liver transplant, a Japanese woman has beaten the odds. This 60-year-old with Hepatitis C, cirrhosis, liver cancer and diabetes, is the first reported case where a liver transplant led to a complete recovery from Hepatitis C.
Continue reading »As reported in the August 21, 2007 edition of the World Journal of Gastroenterology, researchers investigated why some people are able to spontaneously recover from the Hepatitis C virus. This study found the following factors responsible for a person's ability, or inability, to self-recover from the virus - quantity of Hepatitis C antibody, co-infection with Hepatitis B, and the active use of IV drugs.
Continue reading »Using inactivated Hepatitis C particles, a Japanese company has successfully suppressed the Hepatitis C virus in mice. This scientific development holds enormous potential as a Hepatitis C vaccine and possibly as a therapeutic medication for those already infected.
Continue reading »Learn about Implicit Bioscience's drug, Oglufanide Disodium, now in a Phase IIa clinical trial to test its ability for overpowering Hepatitis C.
Continue reading »More people are currently living with Hepatitis C than any other chronic blood-borne infectious disease. Many patients still suffer with the associated stigma in many social circles. Discover two ways to reduce this unfortunate perception of a Hepatitis C diagnosis. Your efforts can help make the changes required.
Continue reading »For HCV genotype 1 patients who have failed to respond to standard therapy (peginterferon and ribavirin), Romark Laboratories has designed a clinical trial to test the safety and effectiveness of Alinia (nitazoxanide). Learn more about the Phase II clinical trial during which nitazoxanide tablets are administered in combination with Pegasys and Copegus, in 60 patients with the most common genotype in North America.
Continue reading »The Chinese University of Hong Kong recently made public the results of its three-year study, which evaluated the use of interferon beta-1a and its combination with ribavirin in the treatment of Asian chronic Hepatitis C patients. Find out how it compares to the existing peginterferon-alfa based therapy.
Continue reading »Learn why the Durham Region Health Department is concerned that nearly 2,000 people may have been exposed to diseases such as Hepatitis B, Hepatitis C and HIV over an eight-month time span at a tattoo and body-piercing shop in Oshawa, Ontario (Canada).
Continue reading »Discover the results of a recent study in Italy that examined the relationship between coffee consumption and the risk of liver cancer, as well as the favorable effects of some of coffee's components.
Continue reading »Learn why a certain hepatitis virus can pose trouble in communal waters, as well as ways to prevent and minimize this swimming pool risk.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
